Yulia Slavina

Solid Biosciences Inc. joins BAA 10K to fund cancer research advancement

Solid Biosciences Inc. joins BAA 10K to fund cancer research advancement
Solid Biosciences Inc. in cancer 10K

Solid Biosciences Inc. participated in the Boston Athletic Association's 10K race, sponsored by Mass General Brigham Cancer Institute, to raise funds for cancer research and patient care.

The company stated that the proceeds from the event will be directed toward advancing cutting-edge research, enhancing medical care, and improving outcomes for those affected by cancer. The initiative demonstrates the company's ongoing commitment to supporting patients and families facing cancer diagnosis and treatment. Details about the specific research initiatives supported by the funding are expected to be provided in future updates.

Solid Biosciences Inc. has previously attended and sponsored the Parent Project Muscular Dystrophy Conference in Orlando to support the Duchenne community. The company also presented clinical insights on its SGT-003 gene therapy candidate for DMD at a major scientific congress, providing updates on its research pipeline. These activities reflect its engagement with both patient advocacy and clinical research initiatives.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.